Paul Knaapen

Showing 1-5 of 5 articles

Author Stefan P. Schumacher

Coronary interventions

Relationship between Extent of Ischaemic Burden and Changes in Absolute Myocardial Perfusion after Chronic Total Occlusion Percutaneous Coronary Intervention

Schumacher S, Kockx M, Stuijfzand W, Driessen R, van Diemen PA, Bom MJ, Everaars H, Raijmakers P, Boellaard R, van Rossum A, Opolski MP, Nap A, Knaapen P

September 24, 2019 | 10.4244/EIJ-D-19-00631

Author Nina W. van der Hoeven

Coronary interventions

Comprehensive physiological evaluation of epicardial and microvascular coronary domains using vascular conductance and zero flow pressure

van der Hoeven NW, de Waard G, Quiros A, de Hoyos A, Broyd C, Nijjer S, van de Hoef T, Petraco R, Driessen R, Mejia-Renteria H, Kikuta Y, Pinto M, Van de Ven P, Meuwissen M, Knaapen P, Piek J, Davies J, van Royen N, Escaned J

February 7, 2019 | 10.4244/EIJ-D-18-00021

Author Wijnand J. Stuijfzand

Coronary interventions

Effects of successful percutaneous coronary intervention of chronic total occlusions on myocardial perfusion and left ventricular function

Stuijfzand W, Biesbroek P, Raijmakers P, Driessen R, Schumacher S, van Diemen P, van den Berg J, Nijveldt R, Lammertsma A, Walsh S, Hanratty C, Spratt J, van Rossum A, Nap A, van Royen N, Knaapen P

June 20, 2017 | 10.4244/EIJ-D-16-01014

Author Maurits R. Hollander

Coronary interventions

Non-invasive assessment of the collateral circulation in the hand: validation of the Nexfin system and relation to clinical outcome after transradial catheterisation

Hollander M, van Leeuwen M, van der Heijden D, Keizer V, Van de Ven P, IJsselmuiden S, Van Mieghem N, Amoroso G, Ritt M, Knaapen P, van Royen N

February 20, 2017 | 10.4244/EIJ-D-16-00337

Author Wijnand J. Stuijfzand

Coronary interventions

Evaluation of myocardial blood flow and coronary flow reserve after implantation of a bioresorbable vascular scaffold versus metal drug-eluting stent: an interim one-month analysis of the VANISH trial

Stuijfzand W, Raijmakers P, Driessen R, Lammertsma A, van Rossum A, Nap A, Appelman Y, Lemkes J, van Leeuwen M, van Royen N, Knaapen P

August 5, 2016 | 10.4244/EIJV12I5A98

1

Latest news

Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue

(Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right))

December 6, 2019

Discover 5 new trials: GALILEO, CONDI-2/ERIC-PCI, EVOLUTE II-5 years, SCOPE and Excel 5 years

(The Trials book is supported by Biotronik)

December 13, 2019

New this week: A Dose-response Meta Analysis, stroke after MitraClip and more

December 10, 2019

The challenge of innovation for the (interventional?) cardiology world

December 6, 2019

Guidance Papers

Guidelines, consensus & position papers

2019 – A leap year for valvular heart disease

(Course directors PCR London Valves 2019)

November 15, 2019

Last week's JAA's: EXTREME Study, Stent Optimization and more

December 3, 2019

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke